Healthy Extracts Q2 Revenue Jumps 113% on Acquisitions, Gross Margin Hits 70%
HYEX sits 68% above its 52-week low of $0.805 on light trading volume (0.2× avg).
Summary
Final Q2 results confirm strong acquisition-driven growth: net revenue rose 113% to $2.07 million, gross profit climbed 145% with margin expanding to 70.3% from 61.2%. The company posted a modest net loss of $129,000 due to higher operating and interest expenses. Management targets annualized revenue above $20 million by year end, calling it aggressive. This follows the preliminary revenue report on Aug 6 and the 10-Q filed today, which also disclosed going concern doubt and a $5.4 million insider loan. The initial Imaraïs Beauty order shipped to over 4,000 U.S. stores, supporting the retail expansion narrative. Watch for H2 2026 execution on the Imaraïs manufacturing ramp and whether the $20 million annualized target is met.
At the time of this announcement, HYEX was trading at $1.35 on OTC in the Life Sciences sector, with a market capitalization of approximately $19.9M. The 52-week trading range was $0.81 to $4.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.